These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 25436681)

  • 1. Toward realization of the promise of regenerative medicine.
    Wakao H
    Horm Mol Biol Clin Investig; 2012 Jun; 10(2):249-53. PubMed ID: 25436681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.
    Togashi Y; Chamoto K; Wakita D; Tsutsumi N; Iwakura Y; Matsubara N; Kitamura H; Nishimura T
    Cancer Sci; 2007 May; 98(5):721-5. PubMed ID: 17359285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKT cells: from totipotency to regenerative medicine.
    Wakao H
    Arch Immunol Ther Exp (Warsz); 2009; 57(2):117-28. PubMed ID: 19333728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
    Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
    Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
    Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of γδ T cells in α-galactosylceramide-mediated immunity.
    Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ
    J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.
    Maeda M; Yanagawa Y; Iwabuchi K; Minami K; Nakamaru Y; Takagi D; Fukuda S; Onoé K
    Immunobiology; 2007; 212(7):537-47. PubMed ID: 17678711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection.
    Joyee AG; Uzonna J; Yang X
    J Immunol; 2010 Feb; 184(4):2095-106. PubMed ID: 20089704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer T cells are critical for dendritic cells to induce immunity in Chlamydial pneumonia.
    Joyee AG; Qiu H; Fan Y; Wang S; Yang X
    Am J Respir Crit Care Med; 2008 Oct; 178(7):745-56. PubMed ID: 18596223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
    Kikuchi A; Nieda M; Schmidt C; Koezuka Y; Ishihara S; Ishikawa Y; Tadokoro K; Durrant S; Boyd A; Juji T; Nicol A
    Br J Cancer; 2001 Sep; 85(5):741-6. PubMed ID: 11531261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis.
    Shibolet O; Kalish Y; Klein A; Alper R; Zolotarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    J Leukoc Biol; 2004 Jan; 75(1):76-86. PubMed ID: 14557387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
    Huang Y; Jiang EL; Zhou Z; He Y; Wang M; Liu QG; Zhai WJ; Han MZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):315-20. PubMed ID: 16038267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction.
    Mizuuchi K; Yanagawa Y; Iwabuchi K; Namba K; Kitaichi N; Ohno S; Onoé K
    Immunology; 2008 May; 124(1):102-11. PubMed ID: 18194275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
    Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
    J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.